The data suggest that SCC express higher levels (4+/3+) of CD44 and ALDH than adenocarcinoma, and co localization of these markers (the CD44hi/ALDHhi surface phenotype) is also easier to identify in SCC (n = 5/7) than in adenocarcinoma (n = 1/12). This evidence concerns the gene CD44 and adenocarcinoma.